DanCann Pharma A/S to refocus its strategy - will reinvigorate its pipeline and product portfolio, and start looking for future owner or partnership for BP1
COPENHAGEN, Denmark, 31 August 2023 – DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby inform the market of a significant change in its strategic business focus, effective immediately. This shift reflects the commitment to adapt to evolving market dynamics and position DanCann Pharma for sustainable growth.The new strategic direction will build upon the existing strengths, notably CannGros. Going forward, the Company will significantly increase its emphasis on sourcing, distribution, and sales within the